FDA Grants Breakthrough Device Designation for Whole Genome and Exome Tests
The designation accelerates regulatory review for GeneDx’s ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
Read MorePosted by CLP Edit Staff | Oct 27, 2025 | Molecular Diagnostic Analyzers |
The designation accelerates regulatory review for GeneDx’s ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
Read MorePosted by CLP Edit Staff | Oct 23, 2025 | Cancer |
German laboratory brings tumor-informed MRD testing to European market through licensing agreement with Quest Diagnostics subsidiary.
Read MorePosted by CLP Edit Staff | Oct 20, 2025 | Transfusion & Transplantation Tests |
The card pairs with the Ortho Vision Platform to provide a complete gel-based DAT solution for transfusion medicine laboratories.
Read MorePosted by CLP Edit Staff | Oct 20, 2025 | Microbiology Instruments |
New clearances expand MALDI-TOF platform capabilities with improved software, faster sample prep, and broader species coverage.
Read MorePosted by CLP Edit Staff | Oct 16, 2025 | Analytical Software Systems |
The CLIA-lab test marks HistoIndex’s expansion from research to routine diagnostics, offering AI-based digital pathology for quantitative liver fibrosis assessment in patients with MASH.
Read More